Search
Unravelling the MYSTICal
- Amit Roy
- Oct 13, 2016
- 1 min read
Astra's underappreciated oncology pipeline stalking the market
We initiate on AstraZeneca with an overweight rating and a Target Price of £56, finding that Astra’s oncology pipeline is underappreciated
コメント